AUM $40.1MER 0.50%NAV $28.27Holdings 99Inception May 2016
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
N/AAvg Volume
13.7KDividend Yield
1.13%Expense Ratio
0.50%AUM
$40.1MShares Outstanding
1.4METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 94.26% |
| Real Estate | 5.74% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 61.70% |
| Other | 10.06% |
| Switzerland | 8.38% |
| Japan | 6.94% |
| United Kingdom | 3.47% |
| China | 2.91% |
| Ireland | 2.50% |
| Korea (the Republic of) | 1.32% |
| Australia | 0.67% |
| Germany | 0.66% |
| Jersey | 0.56% |
| Cayman Islands | 0.36% |
| Canada | 0.23% |
| France | 0.22% |
Fund Information
- Issuer
- Global X
- Category
- Healthcare
- Inception Date
- May 9, 2016
- Description
- The investment seeks results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index. The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
Similar ETFs
The Global X Aging Population ETF (LNGR) is an exchange-traded fund issued by Global X that launched on May 9, 2016. It currently manages $40.1M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 99 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 34.8% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | LLY | ELI LILLY & CO | 4.04% | 4,570 | $1.7M |
| 2 | AMGN | AMGEN INC | 3.84% | 5,592 | $1.6M |
| 3 | BMY | BRISTOL-MYERS SQUIBB CO | 3.56% | 18,552 | $1.5M |
| 4 | REGN | REGENERON PHARMACEUTICALS | 3.52% | 1,973 | $1.5M |
| 5 | NOVOB DC | NOVO NORDISK A/S-B | 3.48% | 12,079 | $1.4M |
| 6 | BSX | BOSTON SCIENTIFIC CORP | 3.35% | 31,355 | $1.4M |
| 7 | JNJ | JOHNSON & JOHNSON | 3.29% | 7,670 | $1.4M |
| 8 | BIIB | BIOGEN INC | 3.25% | 4,393 | $1.3M |
| 9 | AZN | ASTRAZENECA PLC-SPONS ADR | 3.24% | 20,238 | $1.3M |
| 10 | ABBV | ABBVIE INC | 3.20% | 8,276 | $1.3M |
| 11 | DXCM | DEXCOM INC | 2.98% | 10,973 | $1.2M |
| 12 | SYK | STRYKER CORP | 2.94% | 5,212 | $1.2M |
| 13 | ALC.SW | ALCON INC | 2.91% | 17,686 | $1.2M |
| 14 | RO.SW | ROCHE HOLDING AG-BR | 2.89% | 3,035 | $1.2M |
| 15 | 4519.T | CHUGAI PHARMA CO | 2.69% | 42,523 | $1.1M |
Page 1 of 2
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | — | |
| 1W | — | |
| 1M | — | |
| 3M | — | |
| 6M | — | |
| YTD | — | |
| 1Y | — | |
| 3Y | +0.07% | |
| 5Y | -3.57% |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
—
Current Price
$27.75
52-Week Low
—
Current Yield
1.13%
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | LNGR | Healthcare(212 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.50% | 0.61% | 0.83% |
| AUM | $40.1M | $1.20B | $1.52B |
| Dividend Yield | 1.13% | 3.25% | 1.97% |
| Avg Volume | 13.7K | 344.9K | 699.2K |
| Holdings | 99 | 181 | 66 |
| Performance | |||
| 1-Month Return | — | +5.25% | +3.62% |
| 6-Month Return | — | +6.85% | +8.05% |
| YTD Return | — | +2.72% | +0.08% |
| 1-Year Return | — | +30.99% | +41.48% |
Compare with Another ETF
Search for an ETF to compare with LNGR:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.